研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Indirect Comparison of Linvoseltamab Versus Teclistamab for Triple-Class Exposed (TCE) Relapsed/refractory Multiple Myeloma (RRMM)
Sundar Jagannath,Hans C. Lee,Joshua Richter,Jeffrey A. Zonder,James E. Hoffman, Zheng‐Yi Zhou, Viviana Garcia Horton,Mirko Fillbrunn, Hongjue Wang, Matthew Mattera,Qiufei Ma, Timothy J. Inocencio, Yu Xu, Evelien Bergrath,James Harnett, Tito Roccia,Glenn S. Kroog,Karen Rodriguez-Lorenc,Yariv Houvras,Naresh Bumma
Journal of clinical oncologyno. 16_suppl (2024): 7560-7560
引用0浏览0引用
0
0
P-403 Indirect Comparison of Linvoseltamab Versus Selinexor Plus Dexamethasone for Penta-Exposed Relapsed/Refractory Multiple Myeloma (RRMM)
Jeffrey Zonder,Hans Lee,Joshua Richter,Naresh Bumma,Zheng-Yi Zhou, Viviana Garcia-Horton,Mirko Fillbrunn, Hongjue Wang, Matthew Mattera, Wenxin Ma,Qiufei Ma, Timothy Inocencio,Yingxin Xu, Evelien Bergrath,James Harnett, Tito Roccia,Glenn S. Kroog, Karen Rodriguez Lorenc,Yariv Houvras,Sundar Jagannath
Clinical Lymphoma Myeloma and Leukemia (2024): S267
引用0浏览0引用
0
0
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population
Thomas E. Delea,Qiufei Ma,Glenn S. Kroog,Wenzhen Ge,Aaron Moynahan, Natalia Sabater Anaya, Karen Rodriguez Lorenc,Xue Song
Oncology and Therapypp.1-19, (2024)
引用0浏览0WOS引用
0
0
P-402 Indirect Comparison of Linvoseltamab Versus Teclistamab for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): an Updated Analysis Based on 14-Month Follow-Up Data
Hans Lee,Naresh Bumma,Joshua Richter,Jeffrey Zonder,James E. Hoffman,Zheng-Yi Zhou, Viviana Garcia-Horton,Mirko Fillbrunn, Hongjue Wang, Matthew Mattera, Wenxin Ma,Qiufei Ma, Timothy Inocencio,Yingxin Xu, Evelien Bergrath,James Harnett, Tito Roccia,Glenn S. Kroog, Karen Rodriguez Lorenc,Yariv Houvras
Clinical Lymphoma Myeloma and Leukemia (2024): S266-S267
引用0浏览0引用
0
0
P-415 Indirect Comparison of Linvoseltamab Versus Talquetamab for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)
Joshua Richter,Sundar Jagannath,Hans Lee,James E. Hoffman,Jeffrey Zonder, Zheng-Yi Zhou, Viviana Garcia-Horton,Mirko Fillbrunn, Hongjue Wang, Matthew Mattera, Wenxin Ma,Qiufei Ma, Timothy Inocencio,Yingxin Xu, Evelien Bergrath,James Harnett, Tito Roccia,Glenn S. Kroog, Karen Rodriguez Lorenc,Yariv Houvras
Clinical Lymphoma Myeloma and Leukemia (2024): S274-S275
引用0浏览0引用
0
0
P-029 Pharmacokinetics (PK) and Immunogenicity of Linvoseltamab in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) in LINKER-MM1
Anasuya Hazra, Ching-Ha Lai,Dhruti Chokshi,Yariv Houvras,Glenn S. Kroog, Karen Rodriguez Lorenc, A. Thomas DiCioccio, John Davis
Clinical Lymphoma Myeloma and Leukemia (2024): S57
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 22

#Citation: 69

H-Index: 4

G-Index: 8

Sociability: 5

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn